IL134538A - Lactacystin derivatives and pharmaceutical compositions containing the same - Google Patents
Lactacystin derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL134538A IL134538A IL13453898A IL13453898A IL134538A IL 134538 A IL134538 A IL 134538A IL 13453898 A IL13453898 A IL 13453898A IL 13453898 A IL13453898 A IL 13453898A IL 134538 A IL134538 A IL 134538A
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- lactacystin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/80—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91211197A | 1997-08-15 | 1997-08-15 | |
US5584897P | 1997-08-15 | 1997-08-15 | |
US6735297P | 1997-12-03 | 1997-12-03 | |
PCT/US1998/016858 WO1999009006A1 (en) | 1997-08-15 | 1998-08-14 | SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
IL134538A0 IL134538A0 (en) | 2001-04-30 |
IL134538A true IL134538A (en) | 2005-11-20 |
Family
ID=27368920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13453898A IL134538A (en) | 1997-08-15 | 1998-08-14 | Lactacystin derivatives and pharmaceutical compositions containing the same |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1021407A4 (en) |
JP (1) | JP2001515064A (en) |
KR (1) | KR20010022950A (en) |
CN (1) | CN1271342A (en) |
AU (1) | AU749857B2 (en) |
BR (1) | BR9811304A (en) |
CA (1) | CA2301054A1 (en) |
HU (1) | HUP0002724A3 (en) |
IL (1) | IL134538A (en) |
NZ (1) | NZ503169A (en) |
WO (1) | WO1999009006A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4322802A (en) | 2000-11-16 | 2002-06-24 | Univ California | Marine actinomycete taxon for drug and fermentation product dicovery |
CA2443813A1 (en) * | 2001-04-09 | 2002-10-17 | Allan Christian Shaw | Method for identification of proteins from intracellular bacteria |
US7179834B2 (en) | 2002-06-24 | 2007-02-20 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
US7176232B2 (en) | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
US20060199772A1 (en) * | 2002-07-31 | 2006-09-07 | Charite'-Universitaetsmedizin Berlin | Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
CN101791306A (en) | 2003-06-20 | 2010-08-04 | 加利福尼亚大学董事会 | Salinosporamides and using method thereof |
CA2532066C (en) | 2003-06-20 | 2015-07-28 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
WO2006028525A2 (en) | 2004-04-30 | 2006-03-16 | Nereus Pharmaceuticals, Inc. | [3.2.0] heterocyclic compounds and methods of using the same |
US7579371B2 (en) | 2004-04-30 | 2009-08-25 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
CN101155582B (en) | 2004-12-03 | 2013-04-24 | 达纳-法伯癌症研究公司 | Compositions and methods for treating neoplastic diseases |
BRPI0709474A2 (en) | 2006-04-06 | 2011-07-12 | Nerus Pharmaceuticals Inc | total synthesis of salinosporamide a and its analogues |
US7824698B2 (en) | 2007-02-02 | 2010-11-02 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of Salinosporamide A |
US8394816B2 (en) | 2007-12-07 | 2013-03-12 | Irene Ghobrial | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
BRPI0909661A2 (en) | 2008-03-07 | 2015-08-11 | Nereus Pharmaceuticals Inc | Compound and chemical synthesis and compound formation or preparation methods |
CA2723465A1 (en) | 2008-05-12 | 2009-11-19 | Nereus Pharmaceuticals, Inc. | Proteasome inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7008896A (en) * | 1995-08-21 | 1997-03-12 | Duke University | A method to increase the density of antigen on antigen presenting cells |
-
1998
- 1998-08-14 CA CA002301054A patent/CA2301054A1/en not_active Abandoned
- 1998-08-14 NZ NZ503169A patent/NZ503169A/en unknown
- 1998-08-14 IL IL13453898A patent/IL134538A/en not_active IP Right Cessation
- 1998-08-14 CN CN98809526A patent/CN1271342A/en active Pending
- 1998-08-14 JP JP2000509690A patent/JP2001515064A/en active Pending
- 1998-08-14 EP EP98940885A patent/EP1021407A4/en not_active Withdrawn
- 1998-08-14 WO PCT/US1998/016858 patent/WO1999009006A1/en not_active Application Discontinuation
- 1998-08-14 AU AU89062/98A patent/AU749857B2/en not_active Ceased
- 1998-08-14 KR KR1020007001558A patent/KR20010022950A/en active IP Right Grant
- 1998-08-14 BR BR9811304-6A patent/BR9811304A/en not_active IP Right Cessation
- 1998-08-14 HU HU0002724A patent/HUP0002724A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001515064A (en) | 2001-09-18 |
IL134538A0 (en) | 2001-04-30 |
KR20010022950A (en) | 2001-03-26 |
CN1271342A (en) | 2000-10-25 |
BR9811304A (en) | 2001-11-13 |
NZ503169A (en) | 2001-12-21 |
CA2301054A1 (en) | 1999-02-25 |
EP1021407A1 (en) | 2000-07-26 |
EP1021407A4 (en) | 2001-07-04 |
HUP0002724A2 (en) | 2001-02-28 |
AU8906298A (en) | 1999-03-08 |
AU749857B2 (en) | 2002-07-04 |
HUP0002724A3 (en) | 2001-04-28 |
WO1999009006A1 (en) | 1999-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL138899A0 (en) | Amidene derivatives and pharmaceutical compositions containing the same | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
IL140862A (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the same | |
IL135176A0 (en) | Benzothiazole derivatives and pharmaceutical compositions containing the same | |
IL135589A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing the same | |
IL136941A0 (en) | Sulphonamide derivatives and pharmaceutical compositions containing the same | |
IL136940A0 (en) | Sulphonamide derivatives and pharmaceutical compositions containing the same | |
HUS1200028I1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
IL133613A0 (en) | Epothilone derivatives and pharmaceutical compositions containing same | |
IL144977A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
IL143920A0 (en) | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same | |
HUP0004398A3 (en) | Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same | |
HUP0001541A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
HUP9900424A2 (en) | Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
ZA982872B (en) | Pharmaceutical formulation | |
IL136937A0 (en) | τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
HUP0100470A3 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
IL134538A (en) | Lactacystin derivatives and pharmaceutical compositions containing the same | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |